← All Posts
May 27, 2026
•
Author: Phil Ratcliff
| Item |
Proposal |
Vote |
| 1 |
To elect the eleven nominees for director named in the accompanying Proxy Statement to hold office until the next Annual Meeting of Stockholders. |
|
| 1a |
Mary C. Beckerle, Ph.D. |
✓ For(62.452)
|
| 1b |
S. Gail Eckhardt, M.D. |
✓ For(62.452)
|
| 1c |
Maria C. Freire, Ph.D. |
✓ For(62.452)
|
| 1d |
Tomas J. Heyman |
✓ For(62.452)
|
| 1e |
David E. Johnson |
✓ For(62.452)
|
| 1f |
Michael M. Morrissey, Ph.D. |
Withhold(62.452)
|
| 1g |
Robert L. Oliver, Jr. |
✓ For(62.452)
|
| 1h |
Stelios Papadopoulos, Ph.D. |
✓ For(62.452)
|
| 1i |
George Poste, DVM, Ph.D., FRS |
✓ For(62.452)
|
| 1j |
Julie Anne Smith |
✓ For(62.452)
|
| 1k |
Jack L. Wyszomierski |
✓ For(62.452)
|
| 2 |
To ratify the selection by the Audit Committee of the Board of Directors of Ernst & Young LLP as Exelixis' independent registered public accounting firm for the fiscal year ending January 1, 2027. |
✗ Against(62.452)
|
| 3 |
To amend and restate the Exelixis, Inc. 2017 Equity Incentive Plan to, among other things, increase the number of shares authorized for issuance by 2,000,000 shares. |
✓ For(62.452)
|
| 4 |
To approve, on an advisory basis, the compensation of Exelixis' named executive officers, as disclosed in the accompanying Proxy Statement. |
✓ For(62.452)
|
This article was written for information purposes only and its content should not be
construed by any consumer and/or prospective client as rebel Financial's solicitation
to affect, or attempt to affect transactions in securities, or the rendering of
personalized investment advice for compensation. No client or prospective client should
assume that any such discussion serves as the receipt of, or a substitute for,
personalized advice from rebel Financial, or from any other investment professional.
See our disclosures page for more information.
rebel Financial